ADICET BIO INC (ACET) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:ACET • US0070022076

7.03 USD
+0.59 (+9.16%)
At close: Feb 6, 2026
6.88 USD
-0.15 (-2.13%)
After Hours: 2/6/2026, 8:16:43 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

ACET gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 524 industry peers in the Biotechnology industry. ACET has a great financial health rating, but its profitability evaluates not so good. ACET is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • ACET had negative earnings in the past year.
  • In the past year ACET has reported a negative cash flow from operations.
  • In the past 5 years ACET always reported negative net income.
  • In the past 5 years ACET always reported negative operating cash flow.
ACET Yearly Net Income VS EBIT VS OCF VS FCFACET Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M

1.2 Ratios

  • ACET has a worse Return On Assets (-72.53%) than 63.36% of its industry peers.
  • ACET has a Return On Equity of -88.63%. This is comparable to the rest of the industry: ACET outperforms 49.62% of its industry peers.
Industry RankSector Rank
ROA -72.53%
ROE -88.63%
ROIC N/A
ROA(3y)-47.68%
ROA(5y)-37.04%
ROE(3y)-56.8%
ROE(5y)-44.85%
ROIC(3y)N/A
ROIC(5y)N/A
ACET Yearly ROA, ROE, ROICACET Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50 -100 -150

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for ACET so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACET Yearly Profit, Operating, Gross MarginsACET Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. Health

2.1 Basic Checks

  • The number of shares outstanding for ACET has been increased compared to 1 year ago.
  • ACET has more shares outstanding than it did 5 years ago.
  • ACET has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
ACET Yearly Shares OutstandingACET Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ACET Yearly Total Debt VS Total AssetsACET Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • An Altman-Z score of 13.48 indicates that ACET is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 13.48, ACET belongs to the top of the industry, outperforming 85.88% of the companies in the same industry.
  • ACET has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 13.48
ROIC/WACCN/A
WACCN/A
ACET Yearly LT Debt VS Equity VS FCFACET Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • ACET has a Current Ratio of 7.48. This indicates that ACET is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 7.48, ACET is in the better half of the industry, outperforming 72.90% of the companies in the same industry.
  • A Quick Ratio of 7.48 indicates that ACET has no problem at all paying its short term obligations.
  • With a decent Quick ratio value of 7.48, ACET is doing good in the industry, outperforming 73.09% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 7.48
Quick Ratio 7.48
ACET Yearly Current Assets VS Current LiabilitesACET Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • ACET shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -798.25%.
EPS 1Y (TTM)-798.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1264.71%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 28.49% on average over the next years. This is a very strong growth
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-1241.74%
EPS Next 2Y-214.09%
EPS Next 3Y-114.25%
EPS Next 5Y28.49%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ACET Yearly Revenue VS EstimatesACET Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2028 2029 2030 2031 2032 2033 100M 200M 300M
ACET Yearly EPS VS EstimatesACET Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -20 -40

More info and screens

Find the best growth stocksShow best growing peers

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ACET. In the last year negative earnings were reported.
  • Also next year ACET is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACET Price Earnings VS Forward Price EarningsACET Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACET Per share dataACET EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10 -15

4.3 Compensation for Growth

  • A cheap valuation may be justified as ACET's earnings are expected to decrease with -114.25% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-214.09%
EPS Next 3Y-114.25%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for ACET!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ADICET BIO INC

NASDAQ:ACET (2/6/2026, 8:16:43 PM)

After market: 6.88 -0.15 (-2.13%)

7.03

+0.59 (+9.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-05
Earnings (Next)03-04
Inst Owners1.6%
Inst Owner Change-6.38%
Ins Owners0.01%
Ins Owner Change-0.33%
Market Cap1.08B
Revenue(TTM)N/A
Net Income(TTM)-118.20M
Analysts86.15
Price Target101.59 (1345.09%)
Short Float %N/A
Short Ratio0.45
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.59%
Min EPS beat(2)-9.54%
Max EPS beat(2)8.37%
EPS beat(4)3
Avg EPS beat(4)3.58%
Min EPS beat(4)-9.54%
Max EPS beat(4)13.38%
EPS beat(8)6
Avg EPS beat(8)-1.85%
EPS beat(12)7
Avg EPS beat(12)-14.75%
EPS beat(16)9
Avg EPS beat(16)-3.2%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1210.53%
PT rev (3m)1472.64%
EPS NQ rev (1m)-1500%
EPS NQ rev (3m)-1500%
EPS NY rev (1m)-1500%
EPS NY rev (3m)-1489.63%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)-100%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 8.08
P/tB 8.08
EV/EBITDA N/A
EPS(TTM)-15.36
EYN/A
EPS(NY)-13.22
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.64
OCFYN/A
SpS0
BVpS0.87
TBVpS0.87
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -72.53%
ROE -88.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-47.68%
ROA(5y)-37.04%
ROE(3y)-56.8%
ROE(5y)-44.85%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 32.33%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 7.48
Quick Ratio 7.48
Altman-Z 13.48
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)246.96%
Cap/Depr(5y)333.75%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-798.25%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1264.71%
EPS Next Y-1241.74%
EPS Next 2Y-214.09%
EPS Next 3Y-114.25%
EPS Next 5Y28.49%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y1.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-32.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2.32%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-17.88%
OCF growth 3YN/A
OCF growth 5YN/A

ADICET BIO INC / ACET FAQ

What is the fundamental rating for ACET stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACET.


Can you provide the valuation status for ADICET BIO INC?

ChartMill assigns a valuation rating of 0 / 10 to ADICET BIO INC (ACET). This can be considered as Overvalued.


Can you provide the profitability details for ADICET BIO INC?

ADICET BIO INC (ACET) has a profitability rating of 0 / 10.


How financially healthy is ADICET BIO INC?

The financial health rating of ADICET BIO INC (ACET) is 8 / 10.


What is the expected EPS growth for ADICET BIO INC (ACET) stock?

The Earnings per Share (EPS) of ADICET BIO INC (ACET) is expected to decline by -1241.74% in the next year.